PET in Medullary Thyroid Cancer

作者: I. Ross McDougall

DOI: 10.1007/978-1-59259-995-0_74

关键词: CancerCalcitoninOncologyLymphadenectomyMedullary cavityThyroidMedicineStage (cooking)Multiple endocrine neoplasiaMedullary thyroid cancerInternal medicine

摘要: The optimal treatment for medullary thyroid cancer is total thyroidectomy and central nodal lymphadenectomy at presentation when the primary small has not metastasized significantly (1). In three phenotypes of familial cancer, i.e., multiple endocrine neoplasia (MEN) IIA, MENIIB, screening families patients with a mutation in RET proto-oncogene genetic predisposition diseases allows surgery an even earlier stage (2, 3, 4). Unfortunately, all are treated time. Some sporadic have extensive local distant metastases time diagnosis. It important to define extent disease planning treatment. Other who undergone appropriate found measurable calcitonin level after operation. This implies there residual bed or lymph nodes sites. helpful if site sites production can be identified they amenable removal reoperation.

参考文章(22)
Katja Brandt-Mainz, Stefan P. Müller, Rainer Görges, Bernhard Saller, Andreas Bockisch, The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 27, pp. 490- 496 ,(2000) , 10.1007/S002590050533
Michaela Diehl, Jörn H. Risse, Katja Brandt-Mainz, Markus Dietlein, Karl H. Bohuslavizki, Peter Matheja, Heike Lange, Jan Bredow, Carsten Körber, Frank Grünwald, Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 28, pp. 1671- 1676 ,(2001) , 10.1007/S002590100614
Electron Kebebew, Philip H. G. Ituarte, Allan E. Siperstein, Quan-Yang Duh, Orlo H. Clark, Medullary thyroid carcinoma Cancer. ,vol. 88, pp. 1139- 1148 ,(2000) , 10.1002/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z
Bruce K Adams, Abdulbassier Fataar, Michael J Byrne, Naomi S Levitt, Philip J Matley, None, Pentavalent Technetium-99m (V)-DMSA Uptake in a Pheochromocytoma in a Patient with Sipple's Syndrome The Journal of Nuclear Medicine. ,vol. 31, pp. 106- 108 ,(1990)
Sally F. Barrington, Michael N. Maisey, Skeletal Muscle Uptake of Fluorine-18-FDG: Effect of Oral Diazepam The Journal of Nuclear Medicine. ,vol. 37, pp. 1127- 1129 ,(1996)
Christian Cohade, Richard L. Wahl, Karen A. Mourtzikos, "USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. The Journal of Nuclear Medicine. ,vol. 44, pp. 1267- 1270 ,(2003)
Stefan Adams, Richard Baum, Thomas Rink, Petra-Maria Schumm-Dräger, Klaus-Henning Usadel, Gustav Hör, Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 25, pp. 79- 83 ,(1997) , 10.1007/S002590050197
Jean-Louis Baulieu, Denis Guilloteau, Marie-Joelle Delisle, Remy Perdrisot, Paule Gardet, Nicole Delépine, Françoise Baulieu, Jean-Louis Dupont, Jean-Noël Talbot, Gerard Coutris, Claude Calmettes, Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study. Cancer. ,vol. 60, pp. 2189- 2194 ,(1987) , 10.1002/1097-0142(19871101)60:9<2189::AID-CNCR2820600913>3.0.CO;2-C
A. Bockisch, Katja Brandt-Mainz, R. Gorges, St. Muller, J. Stattaus, G. Antoch, Diagnosis in Medullary Thyroid Cancer with [18F]FDG‐PET and Improvement Using a Combined PET/CT Scanner Acta Medica Austriaca. ,vol. 30, pp. 22- 25 ,(2003) , 10.1046/J.1563-2571.2003.02045.X
Gary J. R. Cook, Michael N. Maisey, Ignac Fogelman, Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 26, pp. 1363- 1378 ,(1999) , 10.1007/S002590050597